Valuation: Mega Lifesciences

Market Cap 28.55B 847M 757M 696M 632M 1.18B 80.65B 1.21B 8.33B 3.32B 42.34B 3.18B 3.11B 135B P/E 2026 *
12.5x
P/E 2027 * 11.5x
Enterprise Value 23.94B 710M 635M 584M 530M 992M 67.61B 1.01B 6.99B 2.78B 35.5B 2.66B 2.61B 113B EV / Sales 2026 *
1.67x
EV / Sales 2027 * 1.54x
Free-Float
38.66%
Yield 2026 *
5.44%
Yield 2027 * 5.83%
1 day-3.68%
1 week-2.24%
Current month-2.96%
1 month-5.07%
3 months-12.67%
6 months-6.43%
Current year-2.24%
1 week 32.5
Extreme 32.5
34.75
1 month 32.5
Extreme 32.5
34.75
Current year 31.5
Extreme 31.5
40
1 year 28.75
Extreme 28.75
40
3 years 24.3
Extreme 24.3
44.25
5 years 24.3
Extreme 24.3
56.5
10 years 17.9
Extreme 17.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 1987-12-31
Director of Finance/CFO 62 1996-12-31
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 62 1997-12-31
Director/Board Member 64 2012-12-31
Director/Board Member 73 2013-01-31
Change 5-day change 1-year change 3-year change Capi.($)
-3.68%-2.24% - - 877M
+6.63%+8.10%+67.50%+145.20% 1,148B
+1.53%+6.76%+47.22%+89.01% 652B
+1.68%+2.10%+27.80%+109.31% 505B
+0.73%+2.47%+53.85%+68.96% 384B
+3.83%-2.37%+68.14%+42.32% 348B
+2.38%+4.27%+33.81%+57.95% 294B
+2.26%+3.47%+5.21%+28.92% 264B
+1.97%+5.11%+57.74%+76.14% 244B
+4.03%+7.84%+40.49%+116.14% 197B
Average +0.87%+1.39%+44.64%+81.55% 448.57B
Weighted average by Cap. +1.06%+1.50%+49.58%+95.97%

Financials

2026 *2027 *
Net sales 14.33B 425M 380M 349M 317M 594M 40.47B 605M 4.18B 1.67B 21.25B 1.6B 1.56B 67.76B 15.5B 460M 411M 378M 343M 642M 43.78B 655M 4.52B 1.8B 22.98B 1.73B 1.69B 73.28B
Net income 2.24B 66.54M 59.48M 54.69M 49.67M 92.98M 6.34B 94.72M 655M 261M 3.33B 250M 244M 10.61B 2.49B 73.74M 65.92M 60.61M 55.04M 103M 7.02B 105M 726M 289M 3.69B 277M 271M 11.75B
Net Debt -4.62B -137M -122M -113M -102M -191M -13.04B -195M -1.35B -537M -6.85B -514M -503M -21.83B -4.72B -140M -125M -115M -105M -196M -13.33B -199M -1.38B -549M -7B -525M -514M -22.32B
Projected Income Statement - Annual - Mega Lifesciences
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
26-10-29 THB 32.75 -3.68% 2,371,500
26-10-28 THB 34.00 0.00% 934,500
26-10-27 THB 34.00 -0.73% 2,093,700
26-10-26 THB 34.25 -0.72% 1,847,000
26-10-22 THB 34.50 +2.99% 710,200
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Mega Lifesciences
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
32.75THB
Average target price
42.71THB
Spread / Average Target
+30.43%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Mega Lifesciences